TAUBE HODSON STONEX PARTNERS LLP ANNOUNCE 5.14% SHAREHOLDING IN ABLYNX

GHENT, Belgium, July 1, 2015 (GLOBE NEWSWIRE) -- Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market (the "Transparency Law"), that it received a notification of shareholdings from Taube Hodson Stonex Partners LLP.

Taube Hodson Stonex Partners LLP notified that they have increased their stake in Ablynx and have exceeded the 5% threshold. Taube Hodson Stonex Partners LLP now hold 2,796,302 Ablynx shares, which represent 5.14% of the current 54,407,572 outstanding shares of Ablynx.

Full versions of all transparency notifications are available on the website of Ablynx, under the section Investors.

About Ablynx

Ablynx is a biopharmaceutical company engaged in the development of Nanobodies®, proprietary therapeutic proteins based on single-domain antibody fragments, which combine the advantages of conventional antibody drugs with some of the features of small-molecule drugs. Ablynx is dedicated to creating new medicines which will make a real difference to society. Today, the Company has more than 30 proprietary and partnered programmes in development in various therapeutic areas including inflammation, haematology, immuno-oncology, oncology and respiratory disease. The Company has collaborations with multiple pharmaceutical companies including AbbVie, Boehringer Ingelheim, Eddingpharm, Genzyme, Merck & Co., Inc., Merck Serono, Novartis and Taisho Pharmaceutical Co., Ltd. The Company is headquartered in Ghent, Belgium. More information can be found on www.ablynx.com.

For more information, please contact Ablynx: Dr Edwin Moses CEO t:   +32 (0)9 262 00 07 m: +32 (0)473 39 50 68 e:  [email protected]

Marieke Vermeersch Associate Director Investor Relations t:   +32 (0)9 262 00 82 m: +32 (0)479 49 06 03 e:  [email protected] Follow us on Twitter @AblynxABLX

Ablynx media relations Consilium Strategic Communications: Mary-Jane Elliott, Jonathan Birt, Amber Bielecka, Lindsey Neville t:   +44 203 709 5700 e:  [email protected]

pdf format of the press release http://hugin.info/137912/R/1933131/695732.pdf

HUG#1933131

You May Also Be Interested In

• New Meme Coins for Late August: $BULLSKI Leads the Fresh Entries
• As Global Fuel Markets Whipsaw Through Historic Volatility, JSV Global's Jason Venturelli Calls for a New Playbook on Fuel Risk
• Zcash Price Rockets 50% on ETF Buzz as Best Crypto To Buy Now AlphaPepe Targets a Bigger Percentage Move